发明名称 Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies and compositions thereof
摘要 <p>A recombinant melusin fusion protein having an improved stability and a capability to reach intracellular compartments as compared to recombinant melusin in vivo , wherein said protein comprises i) a human melusin protein having the amino acid sequence as defined in SEQ ID No.:1, or a homologue thereof having at least 60%, preferably at least 80%, more preferably at least 90% sequence identity to SEQ ID No.:1 and having the function of native melusin protein or a human melusin portion derived from SEQ ID No.:1 or homologue thereof having at least 60%, preferably at least 80%, more preferably at least 90% sequence identity of the melusin portion derived from SEQ ID No.:1 and having the function of native melusin protein and ii) a cell penetrating polypeptide.</p>
申请公布号 EP2386570(B1) 申请公布日期 2014.02.26
申请号 EP20110165329 申请日期 2011.05.09
申请人 TARGET HEART BIOTEC S.R.L. 发明人 ACCORNERO, FEDERICA;BRANCACCIO, MARA;TARONE, GUIDO;LEMBO, GIUSEPPE;CARNEVALE, DANIELA
分类号 C07K14/46;A61K38/17;C12N15/12 主分类号 C07K14/46
代理机构 代理人
主权项
地址